Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Inflammation
Published in: Inflammation 1/2023

10-09-2022 | Erythropoietin | Original Article

Mechanistic Approach for Protective Effect of ARA290, a Specific Ligand for the Erythropoietin/CD131 Heteroreceptor, against Cisplatin-Induced Nephrotoxicity, the Involvement of Apoptosis and Inflammation Pathways

Authors: Nasrin Ghassemi-Barghi, Zeynab Ehsanfar, Omid Mohammadrezakhani, Sorour Ashari, Shamim Ghiabi, Zahra Bayrami

Published in: Inflammation | Issue 1/2023

Login to get access

Abstract

ARA 290, an 11-amino acid linear nonhematopoietic peptide derived from the three-dimensional structure of helix B of the erythropoietin (EPO), interacts selectively with the innate repair receptor (IRR) that arbitrates tissue protection. The aim of this study was to investigate the protective effects of ARA290 against cisplatin-induced nephrotoxicity. For this purpose, HEK-293 and ACHN cells were treated with ARA290 (50–400 nM) and cisplatin (2.5 μM) in pretreatment condition. Then, cytotoxicity, genotoxicity, oxidative stress parameters (ROS, GPx, SOD, and MDA), and inflammatory markers (TNFα, IL6, and IL1β) were evaluated. Furthermore, apoptotic cell death was assessed via caspase-3 activity and tunnel assay. To determine the molecular mechanisms of the possible nephroprotective effects of ARA290, gene and protein expressions of TNFα, IL1β, IL6, Caspase-3, Bax, and Bcl2 were evaluated by real-time PCR and western blot assay, respectively. The findings indicated that ARA290 significantly reduced the DNA damage parameters of comet assay and the frequency of micronuclei induced by cisplatin. Besides, ARA290 improved cisplatin-induced oxidative stress by reducing MDA/ROS levels and enhancing antioxidant enzyme levels. In addition, reduced levels of pro-inflammatory cytokines indicated that cisplatin-induced renal inflammation was mitigated upon the treatment with ARA290. Besides, ARA290 ameliorates cisplatin-induced cell injury by antagonizing apoptosis. Furthermore, the molecular findings indicated that gene and protein levels of TNFα, IL1β, IL6, Caspase-3, and Bax were significantly decreased and gene and protein levels of Bcl2 significantly increased in the ARA290 plus cisplatin group compared with the cisplatin group. These findings revealed that ARA290 as a potent chemo-preventive agent exerted a protective effect on cisplatin-induced nephrotoxicity mostly through its anti-apoptotic, anti-inflammatory, and antioxidant potentials and also suggested that ARA290 might be a new therapeutic approach for patients with acute kidney injury.
Appendix
Available only for authorised users
Literature
1.
Manohar, S., and N. Leung. 2018. Cisplatin nephrotoxicity: A review of the literature. Journal of nephrology 31 (1): 15–25.PubMedCrossRef
2.
Fennell, D., et al. 2016. Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer. Cancer treatment reviews 44: 42–50.PubMedCrossRef
3.
Boot, A., et al. 2018. In-depth characterization of the cisplatin mutational signature in human cell lines and in esophageal and liver tumors. Genome research 28 (5): 654–665.PubMedPubMedCentralCrossRef
4.
Hassani, M., et al. 2019. Cytotoxic effects of duloxetine on MKN45 and NIH3T3 cell lines and genotoxic effects on human peripheral blood lymphocytes. Arquivos de Gastroenterologia 56: 372–376.PubMedCrossRef
5.
Aldossary, S.A. 2019. Review on pharmacology of cisplatin: Clinical use, toxicity and mechanism of resistance of cisplatin. Biomedical and Pharmacology Journal 12 (1): 7–15.CrossRef
6.
Guo, J., et al. 2018. Ferroptosis: A novel anti-tumor action for cisplatin. Cancer research and treatment: Official journal of Korean Cancer Association 50 (2): 445.CrossRef
7.
Shi, M., et al. 2018. Cisplatin nephrotoxicity as a model of chronic kidney disease. Laboratory Investigation 98 (8): 1105–1121.PubMedCrossRef
8.
Shokrzadeh, M., et al. 2019. Metallothionein-2A (rs1610216&rs28366003) gene polymorphisms and the risk of stomach adenocarcinoma. Arquivos de Gastroenterologia 56: 367–371.PubMedCrossRef
9.
Sooklert, K., et al. 2016. Cytoprotective effect of glutaraldehyde erythropoietin on HEK293 kidney cells after silver nanoparticle exposure. International Journal of Nanomedicine 11: 597.PubMedPubMedCentral
10.
Ghassemi-Barghi, N., et al. 2016. Role of recombinant human erythropoietin loading chitosan-tripolyphosphate nanoparticles in busulfan-induced genotoxicity: Analysis of DNA fragmentation via comet assay in cultured HepG2 cells. Toxicology in Vitro 36: 46–52.PubMedCrossRef
11.
Shokrzadeh, M., and N. Ghassemi-Barghi. 2018. Melatonin loading chitosan-tripolyphosphate nanoparticles: Application in attenuating etoposide-induced genotoxicity in HepG2 cells. Pharmacology 102 (1–2): 74–80.PubMedCrossRef
12.
Martin, C., et al. 2017. Erythropoietin-induced cytoprotection in intestinal epithelial cells is linked to system Xc. Experimental Cell Research 352 (2): 202–206.PubMedCrossRef
13.
Schmidt, L.S., et al. 2018. Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: A study protocol for a randomized controlled trial. Trials 19 (1): 1–10.CrossRef
14.
Shokrzadeh, M., et al. 2021. Doxorubicin and doxorubicin-loaded nanoliposome induce senescence by enhancing oxidative stress, hepatotoxicity, and in vivo genotoxicity in male Wistar rats. Naunyn-Schmiedeberg’s Archives of Pharmacology 394 (8): 1803–1813.PubMedCrossRef
15.
Macdougall, I.C. 2018. Development of recombinant erythropoietin and erythropoietin analogs. In Textbook of nephro-endocrinology, 217–232. Elsevier.CrossRef
16.
Shokrzadeh, M., M. Etebari, and N. Ghassemi-Barghi. 2020. An engineered non-erythropoietic erythropoietin-derived peptide, ARA290, attenuates doxorubicin induced genotoxicity and oxidative stress. Toxicology in Vitro 66: 104864.PubMedCrossRef
17.
Hache, G., et al. 2016. ARA290, a specific agonist of erythropoietin/CD131 heteroreceptor, improves circulating endothelial progenitors’ angiogenic potential and homing ability. Shock: Injury, Inflammation, and Sepsis: Laboratory and Clinical Approaches, 46(4): 390–397.
18.
Watanabe, M., et al. 2016. An engineered innate repair receptor agonist, ARA 290, protects rat islets from cytokine-induced apoptosis. Journal of Diabetes and Metabolism 7 (708): 2.
19.
Shokrzadeh, M., M. Etebari, and N. Ghassemi-Barghi. 2020. An engineered non-erythropoietic erythropoietin-derived peptide, ARA290, attenuates doxorubicin induced genotoxicity and oxidative stress. Toxicology in Vitro, p. 104864.
20.
Ghassemi-Barghi, N., M. Etebari, and A. Jafarian-Dehkordi. 2017. Protective effect of amifostine on busulfan induced DNA damage in human hepatoma cells. Toxicology Mechanisms and Methods 27 (1): 52–57.PubMedCrossRef
21.
Zhang, H., et al. 2018. EPO derivative ARA290 attenuates early renal allograft injury in rats by targeting NF.
22.
Zhang, Y., et al. 2017. Renoprotection and mechanisms of erythropoietin and its derivatives helix b surface peptide in kidney injuries. Current Protein and Peptide Science 18 (12): 1183–1190.PubMedCrossRef
23.
Dobyan, D.C., et al. 1980. Mechanism of cis-platinum nephrotoxicity: II. Morphologic observations. Journal of Pharmacology and Experimental Therapeutics, 213(3): 551–556.
24.
Kumar, P., A. Nagarajan, and P.D. Uchil. 2018. Analysis of cell viability by the MTT assay. Cold Spring Harbor Protocols, 2018(6): p. pdb. prot095505.
25.
Hassani, M., et al. 2019. Cytotoxic effects of duloxetine on MKN45 and NIH3T3 cell lines and genotoxic effects on human peripheral blood lymphocytes. Arquivos de gastroenterologia, 56 (4): 372–376.
26.
Shokrzadeh, M., and N. Ghassemi-Barghi. 2018. Application of comet assay to assess the protective effect of amifostine on doxorubicin-induced DNA damage in human hepatoma cells. EC Pharmacology and Toxicology 6: 500–508.
27.
Shokrzadeh, M., et al. 2019. Cytotoxic effects of aripiprazole on MKN45 and NIH3T3 cell lines and genotoxic effects on human peripheral blood lymphocytes. Arquivos de gastroenterologia, 56(2): 155–159.
28.
Yao, J., et al. 2019. Reversing ROS-mediated neurotoxicity by chlorogenic acid involves its direct antioxidant activity and activation of Nrf2-ARE signaling pathway. BioFactors 45 (4): 616–626.PubMed
29.
Moura, C.S., et al. 2017. Modulatory effects of arginine, glutamine and branched-chain amino acids on heat shock proteins, immunity and antioxidant response in exercised rats. Food & function 8 (9): 3228–3238.CrossRef
30.
Ren, Y., et al. 2019. Si-Miao-Yong-An decoction ameliorates cardiac function through restoring the equilibrium of SOD and NOX2 in heart failure mice. Pharmacological Research 146: 104318.PubMedCrossRef
31.
Wang, L., et al. 2019. P53-dependent induction of ferroptosis is required for artemether to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation. IUBMB Life 71 (1): 45–56.PubMedCrossRef
32.
Clausen, B.H., et al. 2008. Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice. Journal of neuroinflammation 5 (1): 46.PubMedPubMedCentralCrossRef
33.
Shokrzadeh, M., et al. 2018. Serum cytokine of IL-2, IL-10 and IL-12 levels in patients with stomach adenocarcinoma. Arquivos de gastroenterologia 55: 385–389.PubMedCrossRef
34.
Baharara, J., et al. 2016. Induction of apoptosis by green synthesized gold nanoparticles through activation of caspase-3 and 9 in human cervical cancer cells. Avicenna journal of medical biotechnology 8 (2): 75.PubMedPubMedCentral
35.
Zhong, Y., et al. 2017. Apigenin attenuates patulin-induced apoptosis in HEK293 cells by modulating ROS-mediated mitochondrial dysfunction and caspase signal pathway. Toxicon 137: 106–113.PubMedCrossRef
36.
Lee, Y., et al. 2012. Transient exposure to hydrogen peroxide inhibits the ubiquitination of phosphorylated IκBα in TNFα-stimulated HEK293 cells. Experimental & molecular medicine 44 (8): 513–520.CrossRef
37.
Monjezi, A., et al. 2022. Resistin, TNF-α, and microRNA 124–3p expressions in peripheral blood mononuclear cells are associated with diabetic nephropathy. International Journal of Diabetes in Developing Countries 42 (1): 62–69.CrossRef
38.
Yu, T., et al. 2018. Plumbagin suppresses the human large cell lung cancer cell lines by inhibiting IL-6/STAT3 signaling in vitro. International Immunopharmacology 55: 290–296.PubMedCrossRef
39.
Wang, Y., et al. 2018. PINK1/Parkin-mediated mitophagy is activated in cisplatin nephrotoxicity to protect against kidney injury. Cell death & disease 9 (11): 1–14.CrossRef
40.
Yu, W., et al. 2018. Cisplatin generates oxidative stress which is accompanied by rapid shifts in central carbon metabolism. Scientific reports 8 (1): 1–12.
41.
Wang, S.-W., et al. 2018. Astilbin ameliorates cisplatin-induced nephrotoxicity through reducing oxidative stress and inflammation. Food and chemical toxicology 114: 227–236.PubMedCrossRef
42.
Wang, Z., et al. 2020. Kaempferol ameliorates cisplatin induced nephrotoxicity by modulating oxidative stress, inflammation and apoptosis via ERK and NF-κB pathways. AMB Express 10 (1): 1–11.CrossRef
43.
Li, S., et al. 2019. NLRP3 inflammasome inhibition attenuates cisplatin-induced renal fibrosis by decreasing oxidative stress and inflammation. Experimental Cell Research 383 (1): 111488.PubMedCrossRef
44.
Alibakhshi, T., et al. 2018. Protective effects of zingerone on oxidative stress and inflammation in cisplatin-induced rat nephrotoxicity. Biomedicine & Pharmacotherapy 105: 225–232.CrossRef
45.
Saifi, M.A., et al. 2019. Protective effect of nanoceria on cisplatin-induced nephrotoxicity by amelioration of oxidative stress and pro-inflammatory mechanisms. Biological Trace Element Research 189 (1): 145–156.PubMedCrossRef
46.
Abdel-Wahab, W.M., and F.I. Moussa. 2019. Neuroprotective effect of N-acetylcysteine against cisplatin-induced toxicity in rat brain by modulation of oxidative stress and inflammation. Drug design, development and therapy 13: 1155.PubMedPubMedCentralCrossRef
47.
Heij, L., et al. 2012. Safety and efficacy of ARA 290 in sarcoidosis patients with symptoms of small fiber neuropathy: A randomized, double-blind pilot study. Molecular medicine 18 (11): 1430–1436.PubMedCentralCrossRef
48.
Brines, M., et al. 2014. ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetes. Molecular medicine 20 (1): 658–666.CrossRef
49.
Dahan, A., et al. 2013. ARA 290 improves symptoms in patients with sarcoidosis-associated small nerve fiber loss and increases corneal nerve fiber density. Molecular medicine 19 (1): 334–345.PubMedPubMedCentralCrossRef
50.
Swartjes, M., et al. 2011. ARA290, a peptide derived from the tertiary structure of erythropoietin, produces long-term relief of neuropathic pain: an experimental study in rats and β-common receptor knockout mice. Anesthesiology: The Journal of the American Society of Anesthesiologists, 115 (5): 1084–1092.
51.
van Rijt, W.G., et al. 2013. Renoprotective capacities of non-erythropoietic EPO derivative, ARA290, following renal ischemia/reperfusion injury. Journal of translational medicine 11 (1): 286.PubMedPubMedCentralCrossRef
52.
Watanabe, M., et al. 2016. A nonhematopoietic erythropoietin analogue, ARA 290, inhibits macrophage activation and prevents damage to transplanted islets. Transplantation 100 (3): 554–562.PubMedCrossRef
53.
Zhang, H., et al. 2018. EPO derivative ARA290 attenuates early renal allograft injury in rats by targeting NF-κB pathway. In Transplantation Proceedings Elsevier.
54.
Ansari, M., et al. 2020. New thiazole-2 (3H)-thiones containing 4-(3, 4, 5-trimethoxyphenyl) moiety as anticancer agents. European journal of medicinal chemistry 185: 111784.PubMedCrossRef
55.
Yesildag, K., et al. 2022. Evaluation of oxidative stress, inflammation, apoptosis, oxidative DNA damage and metalloproteinases in the lungs of rats treated with cadmium and carvacrol. Molecular Biology Reports 49 (2): 1201–1211.PubMedCrossRef
56.
Wu, Y. 2020. Heterodimer of erythropoietin receptor and β common receptor in renal ischemia-reperfusion injury and repair. University of Leicester.
57.
Kuhad, A., et al. 2007. Effect of curcumin on inflammation and oxidative stress in cisplatin-induced experimental nephrotoxicity. Journal of agricultural and food chemistry 55 (25): 10150–10155.PubMedCrossRef
58.
Abdel Moneim, A.E., M.S. Othman, and A.M. Aref. 2014. Azadirachta indica attenuates cisplatin-induced nephrotoxicity and oxidative stress. BioMed Research International 2014.
59.
Vigneron, A., and K.H. Vousden. 2010. p53, ROS and senescence in the control of aging. Aging (Albany NY) 2 (8): 471.PubMedCrossRef
60.
Yardim, A., et al. 2022. Investigation of the effects of berberine on bortezomib-induced sciatic nerve and spinal cord damage in rats through pathways involved in oxidative stress and neuro-inflammation. Neurotoxicology 89: 127–139.PubMedCrossRef
61.
Gur, C., O. Kandemir, and F.M. Kandemir. 2022. Investigation of the effects of hesperidin administration on abamectin-induced testicular toxicity in rats through oxidative stress, endoplasmic reticulum stress, inflammation, apoptosis, autophagy, and JAK2/STAT3 pathways. Environmental Toxicology 37 (3): 401–412.PubMedCrossRef
62.
Strycharz-Dudziak, M., et al. 2019. Total antioxidant status (TAS), superoxide dismutase (SOD), and glutathione peroxidase (GPx) in oropharyngeal cancer associated with EBV infection. Oxidative Medicine and Cellular Longevity 2019.
63.
Ashari, S., et al. 2020. The implication of mitochondrial dysfunction and mitochondrial oxidative damage in di (2-ethylhexyl) phthalate induced nephrotoxicity in both in vivo and in vitro models. Toxicology Mechanisms and Methods 30 (6): 427–437.PubMedCrossRef
64.
Kandemir, F.M., M. Ileriturk, and C. Gur. 2022. Rutin protects rat liver and kidney from sodium valproate-induce damage by attenuating oxidative stress, ER stress, inflammation, apoptosis and autophagy. Molecular Biology Reports p. 1–12.
65.
Ebrahimi, R., M. Shokrzadeh, and N. Ghassemi Barghi. 2021. Effects of melatonin on the Bisphenol-A-induced cytotoxicity and genetic toxicity in colon cancer cell lines, normal gingival cell lines, and bone marrow stem cell lines. Cancer Informatics 20: p. 11769351211056295.
66.
67.
68.
Hamad, R., et al. 2015. Honey feeding protects kidney against cisplatin nephrotoxicity through suppression of inflammation. Clinical and Experimental Pharmacology and Physiology 42 (8): 843–848.PubMedCrossRef
69.
Pabla, N., and Z. Dong. 2008. Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies. Kidney international 73 (9): 994–1007.PubMedCrossRef
70.
Kim, D.-H., et al. 2021. The critical role of FXR is associated with the regulation of autophagy and apoptosis in the progression of AKI to CKD. Cell death & disease 12 (4): 1–15.CrossRef
71.
Shokrzadeh, M., et al. 2020. Association between diabetics and intestinal cancer with the risk of mutation in CD38 gene in Iranian population. Arquivos de Gastroenterologia 57: 137–143.PubMedCrossRef
72.
Ahadi, H., et al. 2020. Synthesis and biological assessment of ciprofloxacin-derived 1, 3, 4-thiadiazoles as anticancer agents. Bioorganic Chemistry 105: 104383.PubMedCrossRef
73.
Zhu, H., et al. 2020. PSTPIP2 inhibits cisplatin-induced acute kidney injury by suppressing apoptosis of renal tubular epithelial cells. Cell Death & Disease 11 (12): 1–13.CrossRef
74.
Howell, K., et al. 2017. Specific ligand for the innate repair receptor, ARA290, attenuates pulmonary hypertension in an elastase-induced murine model of emphysema. European Respiratory Society.
75.
Dang, J., Y. Tu, and J. Wang. 2019. ARA290 inhibits oxidative stress in kidney of diabetic rats. Chinese Journal of Nephrology, Dialysis & Transplantation 28 (5): p. 435.
Metadata
Title
Mechanistic Approach for Protective Effect of ARA290, a Specific Ligand for the Erythropoietin/CD131 Heteroreceptor, against Cisplatin-Induced Nephrotoxicity, the Involvement of Apoptosis and Inflammation Pathways
Authors
Nasrin Ghassemi-Barghi
Zeynab Ehsanfar
Omid Mohammadrezakhani
Sorour Ashari
Shamim Ghiabi
Zahra Bayrami
Publication date
10-09-2022
Publisher
Springer US
Published in
Inflammation / Issue 1/2023
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-022-01737-7

Other articles of this Issue 1/2023

Inflammation 1/2023 Go to the issue

Original Article

Silence of S1PR4 Represses the Activation of Fibroblast-like Synoviocytes by Regulating IL-17/STAT3 Signaling Pathway

Original Article

Plasma IL-36α and IL-36γ as Potential Biomarkers in Interstitial Lung Disease Associated with Rheumatoid Arthritis: a Pilot Study in the Chinese Population

Original Article

Pyruvate Dehydrogenase Kinase 2 Accelerates Endotoxin Shock by Promoting Mitogen-Activated Protein Kinase Activation

Original Article

Targeting Oxidative Stress Markers, Xanthine Oxidase, TNFRSF11A and Cathepsin L in Curcumin-Treated Collagen-Induced Arthritis: A Physiological and COSMO-RS Study

Original Article

Macrophage-Derived TGF-β and VEGF Promote the Progression of Trauma-Induced Heterotopic Ossification

Original Article

The Pathogenic Role of Oxidative Stress, Cytokine Expression, and Impaired Hematological Indices in Diabetic Cardiovascular Diseases
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits